Kortenberg, Belgium

Ellen Gommé



Average Co-Inventor Count = 6.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Opvelp, BE (2011)
  • Kortenberg, BE (2013)

Company Filing History:


Years Active: 2011-2013

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Ellen Gommé in Neurodegenerative Disease Treatment

Introduction

Ellen Gommé is a notable inventor based in Kortenberg, Belgium. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative diseases. With a total of two patents to her name, her work focuses on innovative compounds that can potentially improve the lives of those affected by various neurological conditions.

Latest Patents

Ellen Gommé's latest patents include the development of thiadiazole derivatives for the treatment of neurodegenerative diseases. One of her inventions provides specifically substituted 1,2,4-thiadiazole derivatives for use in treating α-synucleopathy, which encompasses conditions such as Parkinson's disease, diffuse Lewy body disease, traumatic brain injury, amyotrophic lateral sclerosis, Niemann-Pick disease, Hallervorden-Spatz syndrome, Down syndrome, neuroaxonal dystrophy, multiple system atrophy, and Alzheimer's disease. Additionally, her inventions outline various methods for producing these substituted derivatives. Another patent focuses on novel 1,2,4-thiadiazole derivatives that are useful for preventing or treating α-synucleopathy, along with pharmaceutical compositions that include these compounds as biologically active ingredients.

Career Highlights

Ellen Gommé is currently associated with Remynd, a company dedicated to advancing research in neurodegenerative diseases. Her work has been instrumental in developing new therapeutic options that could change the landscape of treatment for these challenging conditions.

Collaborations

Ellen collaborates with esteemed colleagues such as Gerard Griffioen and Stefaan Wera, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Ellen Gommé's contributions to the field of neurodegenerative disease treatment through her innovative patents highlight her role as a leading inventor in this critical area of research. Her work continues to pave the way for new therapeutic approaches that may significantly impact patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…